Open AccessHow do mTOR inhibitors fit in the landscape of treatment for relapsed acute lymphoblastic leukemia?
Author(s) -
Ashley Pinchinat,
Elizabeth A. Raetz
Publication year - 2022
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2021.280395
Subject(s) - lymphoblastic leukemia , discovery and development of mtor inhibitors , medicine , pi3k/akt/mtor pathway , oncology , acute lymphocytic leukemia , leukemia , biology , genetics , signal transduction
Not available.